证券记录 · 已归档季度
RNAM
Avidity Biosciences Inc · Healthcare · Biotechnology
11被追踪持有人
—Δ持有人
22.12M持有股份
$903.80M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q4 2025 | 103 | +3 | 81.99M | $5.91B | +5 | −1 |
| Q3 2025 | 15 | 0 | 78.61M | $3.43B | — | −1 |
| Q2 2025 | 13 | -1 | 64.96M | $1.84B | +1 | −2 |
| Q1 2025 | 11 | -2 | 31.61M | $933.16M | — | −2 |
| Q4 2024 | 13 | +1 | 31.55M | $918.65M | +1 | — |
| Q3 2024 | 11 | 0 | 25.98M | $1.19B | +1 | −1 |
| Q2 2024 | 11 | — | 22.12M | $903.80M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.92M | — | $445.94M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.92M | — | $445.94M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 3.80M | — | $155.31M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 3.40M | — | $138.77M | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 2.26M | — | $92.20M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 2.26M | — | $92.20M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 739.04K | — | $30.19M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 739.04K | — | $30.19M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 377.40K | — | $15.42M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 225.75K | — | $9.22M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 160.78K | — | $6.57M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 125.38K | — | $5.12M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Marshall Wace ✦ | 111.77K | — | $4.57M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 12.04K | — | $491,916 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 12.04K | — | $491,916 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 12.04K | — | $491,916 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 8.00K 股份, $236,160 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据